ArticleObesity surgery2026
Splanchnic Vein Thrombosis after Metabolic and Bariatric Surgery: Chilean Position Statement of Hepatology and Bariatric Surgery societies.
Article in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND &
aimsMetabolic and bariatric surgery is one of the most effective interventions for long-term weight loss and metabolic improvement. Splanchnic Vein Thrombosis (SVT) is an uncommon but potentially severe complication with a complex and multidisciplinary management, yet no clinical practice guidelines currently exist in this setting. We aimed to provide practical recommendations to guide healthcare teams in the prevention, diagnosis, and management of SVT after metabolic and bariatric surgery.
methodsA modified Delphi process was conducted in two rounds among 17 experts (seven hepatologists, seven bariatric surgeons, and three interventional radiologists). Statements were generated based on a structured literature review. After the Delphi rounds, statements were refined considering rate and comments. Consensus was predefined as ≥ 80% agreement.
resultsConsensus was reached on seven dimensions of 20 statements (response rate R1 100% and R2 100%): (1) Risk factors related to surgical technique predisposing to SVT; (2) Assessment of candidates for metabolic and bariatric surgery; (3) Diagnosis of SVT; (4) Initial management of acute SVT; (5) Follow-up strategy for patients with SVT; (6) Late complications of SVT; (7) Prophylactic measures to prevent SVT. Recommendations emphasize the need for individualized surgical planning, comprehensive preoperative assessment for thrombotic risk factors, and multidisciplinary management. Additional statements addressed optimal diagnostic imaging, anticoagulation duration, and interventional radiology approaches for refractory or complicated cases.
conclusionsThis consensus provides structured, evidence-informed recommendations for the clinical assessment and management of SVT after metabolic and bariatric surgery. These statements are intended to standardize practice, support multidisciplinary decision-making, and improve patient outcomes in this rare but serious complication.
Indexed as
Identifiers
42778729What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.